| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.15 | 0.3 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |